Stock Updates

Is this Large Market Cap Stock target price reasonable for Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)?

The company in question is, Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) currently with a stock price of 94.2 (-1.81% today). The market cap for Ligand Pharmaceuticals Incorporated is 2026.25, and is in the sector Healthcare, and Biotechnology industry. The target price for Ligand Pharmaceuticals Incorporated is 141.67. Currently Ligand Pharmaceuticals Incorporated is trading with a P/E of 8.85, and a forward P/E of 19.23. Average volume for Ligand Pharmaceuticals Incorporated is 438.02 and so far today it is 120635.

Performance in the last year for Ligand Pharmaceuticals Incorporated has been 8.00%. For EPS growth, Ligand Pharmaceuticals Incorporated has seen a growth of 2.10%, and is looking to grow in the next year to 44.83%. More long term stats show that EPS growth has been 83.10% over the last five years and could be 45.43% for the next five years. Ligand Pharmaceuticals Incorporated has seen sales growth quarter over quarter at 6.00%, with EPS growth quarter over quarter at -125.00%. The 20-day simple moving average is -13.41%, with the 200-day simple moving average coming to -15.12%.

Since the IPO date for Ligand Pharmaceuticals Incorporated on the 11/18/1992, Ligand Pharmaceuticals Incorporated has seen performance year to date to be -11.51%. With Ligand Pharmaceuticals Incorporated trading at 94.2, the dividend yield is *TBA, and the EPS is 10.84.

So could Ligand Pharmaceuticals Incorporated, be undervalued? Well as said before P/E is 8.85. The PEG is 0.19, P/S is 23 and the P/B is at 5.1. The P/cash is 18.94, with P/free cash flow at 70.36.

Ligand Pharmaceuticals Incorporated ability to deal with debt shows that the current ratio is 0.6, and the quick ratio is 0.6. This is with long term debt/equity at 0, and total debt/equity at 0.53.

In terms of margins, Ligand Pharmaceuticals Incorporated has a gross margin of 95.70%, an operating margin of 44.30% and a profit margin of *TBA.Payout ratio for Ligand Pharmaceuticals Incorporated is 0.00%. Return on assets come to 41.00% with return on investment coming to 54.20%.

Insider ownership for Ligand Pharmaceuticals Incorporated, is at 2.40% and institutional ownership comes to *TBA. Outstanding shares are at 21.12. While shares float is 20.09. The float short is currently 20.22%, and short ratio is 9.27.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment